Sterilisation is a crucial process for ensuring safety and quality in the production of drugs, medical devices and biotechnology materials.
With a market estimated at $13.6bn by 2025, the industry is expanding steadily, driven by the rise in hospital infections, the spread of complex surgical procedures, and increasing attention being given to hygiene standards. The Covid-19 pandemic further underscored the importance of advanced solutions for contamination prevention.
Sterilisation techniques and applications
Sterilisation methods vary according to the nature and sensitivity of the materials being treated. Moist heat, considered the most reliable biocidal method, is ideal for porous, non-porous and aqueous solutions. Dry heat finds application for solids, powders and thermostable materials, while gamma irradiation/ethylene oxide and sterilisation by filtration are suitable for heat-sensitive products such as disposable devices and liquid drugs.
LAST Technology is at the forefront of providing customised solutions that address industry-specific needs. The RSA Premium system is a prime example: a machine capable of combining three distinct processes in a single machine, optimising operational efficiency/costs and reducing environmental impact. Terminal sterilisers and steam autoclaves complete the offering, providing flexibility and adaptability to different loads and materials, from ‘sealed’ liquids to the sterilisation of solids and semisolids to high-volume processing.
Innovation and sustainability
In addition to process customisation, LAST Technology focuses on technological innovations that improve efficiency and reduce consumption. For example, vacuum pumps with ‘closed-loop’ systems provide water savings of up to 60%, while modular design reduces footprint and increases installation flexibility. These solutions not only improve operational performance, but also promote sustainable practices in line with international regulations.
LAST Technology stands out for its ability to combine innovation, sustainability and customisation, becoming a strategic partner for pharmaceutical and biotechnology companies. Its advanced systems not only meet current market challenges but anticipate future needs, offering solutions that combine safety, efficiency and environmental friendliness.